William Ashton - Dec 31, 2024 Form 3/A - Amendment Insider Report for Medicus Pharma Ltd. (MDCX)

Role: Director
Signature: /s/ James Quinlan, as Attorney-in-Fact, for William L. Ashton
Stock symbol: MDCX
Transactions as of: Dec 31, 2024
Transactions value $: $0
Form type: 3/A - Amendment
Date filed: 1/23/2025, 06:14 PM
Date Of Original Report: Dec 31, 2024
Previous filing: Apr 8, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	MDCX	Stock Option (right to buy)							Dec 31, 2024	Common Shares	15K	$2.75	Direct	F1, F2, F3

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option was granted on December 17, 2024. The option is scheduled to vest quarterly in four equal installments over one year.
F2	This amendment is being filed to include options that were inadvertently omitted from the Form 3 filed by the Reporting Person on December 31, 2024.
F3	Represents an exercise price of $3.95 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.4379 reported by the Bank of Canada on December 30, 2024.